Form 4 for LEGN Legend Biotech Corp
Accepted 2026-06-29 21:53:13 ET · period of report 2026-06-25 · accession 0001967360-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-29 21:53 | 2026-06-25 | LEGN | Huang Ying | CEO, Dir | S - Sale | $14.78 | -5,566 | 241.9K | -2% | -$82.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-06-25 | S | D | 5,566 | $14.78 | 241,872 | D | — | — | (F1) The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer. (F2) Represents shares sold to satisfy withholding tax obligations upon the vesting of restricted share units. (F3) The price reported in Column 4 is a weighted average price and represents the converted sales price of the ADSs of $29.56. The prices sold ranged from $28.13 to $29.98 per ADS (which is equivalent to $14.065 to $14.99 per ordinary share). The reporting person will provide the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range. |